Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-08-01 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (804 characters) about the company receiving a government subsidy related to the disposal of zombie enterprises. It includes details about the subsidy amount, its intended use, and accounting treatment. There is no financial statement or comprehensive report data. The document is an announcement of a government grant and its impact, not a full financial report or audit. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or officer attestation. Given the content and length, it best fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2018-08-01 Chinese
关于调整公司发行股份购买资产发行价格的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the adjustment of the issuance price of shares for an asset purchase transaction by 中粮生物化学（安徽）股份有限公司. It details the price adjustment mechanism, the adjusted issuance price, the number of shares to be issued, and references prior board and shareholder approvals. The document is not a full financial report but a specific update on a capital transaction related to share issuance for acquisition purposes. It does not contain comprehensive financial statements or management discussion but focuses on the pricing and share issuance adjustment for the transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2631 characters, which is consistent with an announcement rather than a full report.
2018-07-30 Chinese
七届监事会2018年第一次临时会议公告
Capital/Financing Update Classification · 95% confidence The document is an announcement of a supervisory board meeting of COFCO Biochemical (Anhui) Co., Ltd. It details the resolutions passed regarding the adjustment of the share issuance price for an asset acquisition transaction. The text includes voting results, explanations of the price adjustment, and references to related agreements and regulatory compliance. There are no financial statements or comprehensive financial data presented. The document is a formal announcement of decisions made in a board meeting related to capital issuance and transaction pricing adjustments. It is not a full financial report, audit report, or earnings release. Given the content focuses on updates to financing terms and share issuance pricing, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive details about the financing transaction rather than just announcing a report publication, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2018-07-30 Chinese
七届董事会2018年第五次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 2018 fifth extraordinary meeting of the seventh board of directors of COFCO Biochemical (Anhui) Co., Ltd. It includes voting results, descriptions of decisions related to share issuance price adjustments, asset purchase agreements, establishment of a wholly-owned subsidiary, and financing applications. The content focuses on board meeting decisions and corporate governance matters rather than financial results, audit opinions, or regulatory filings. There is no indication that this is a full annual or interim report, earnings release, or audit report. The document is not a simple announcement of voting results but a detailed board meeting resolution announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (4037 characters) and detailed content support this classification with high confidence.
2018-07-30 Chinese
独立董事关于公司七届董事会2018年第五次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters related to the company's 7th board of directors' 2018 fifth extraordinary meeting. It discusses adjustments to the issuance price of shares for an asset purchase transaction, compliance with relevant laws and regulations, and confirms that the adjustments do not constitute a major change to the transaction plan. The document is a formal opinion letter from independent directors regarding a specific board meeting and related transaction matters. It is not a full annual or interim report, nor is it a simple announcement or certification. It relates to board/management decisions and disclosures about a significant transaction and related board resolutions. Therefore, it fits best under Board/Management Information (MANG). The document length is 2254 characters, which is relatively short but contains substantive content about board decisions and independent directors' opinions on a transaction, not just an announcement or notice. Hence, it is not RPA or RNS. Confidence is high due to clear references to board meeting, independent directors' opinions, and transaction adjustments.
2018-07-30 Chinese
关于投资设立全资子公司的公告（已取消）
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's investment to establish a wholly-owned subsidiary. It details the board meeting resolution, investment amount, company information, and the purpose and risks of the investment. There are no financial statements or detailed financial performance data. The document is a formal announcement of a capital investment decision, not a financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through investment in a subsidiary.
2018-07-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.